{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T13:14:24Z","timestamp":1794834864528,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-72997-2","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:56:56Z","timestamp":1778601416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Endothelial cell-secreted SPARC suppresses astrocytic CD59 expression and promotes astrocytopathy in a mouse model of neuromyelitis optica spectrum disorders"],"prefix":"10.1038","volume":"17","author":[{"given":"Tingting","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luhang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaogang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9875-9821","authenticated-orcid":false,"given":"Xiaochang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7438-0489","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7210-8358","authenticated-orcid":false,"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1714-2318","authenticated-orcid":false,"given":"Yaping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"72997_CR1","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/ni.3858","volume":"18","author":"G Hajishengallis","year":"2017","unstructured":"Hajishengallis, G. et al. Novel mechanisms and functions of complement. Nat. Immunol. 18, 1288\u20131298 (2017).","journal-title":"Nat. Immunol."},{"key":"72997_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.tracli.2020.08.007","volume":"27","author":"M Raturi","year":"2020","unstructured":"Raturi, M. & Kala, M. The history and evolution of the \u201ccomplement system\u201d. Transfus. Clin. Biol. 27, 273\u2013274 (2020).","journal-title":"Transfus. Clin. Biol."},{"key":"72997_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/bpa.12099","volume":"24","author":"CF Lucchinetti","year":"2014","unstructured":"Lucchinetti, C. F. et al. The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathol. 24, 83\u201397 (2014).","journal-title":"Brain Pathol."},{"key":"72997_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.immuni.2019.12.004","volume":"52","author":"S Werneburg","year":"2020","unstructured":"Werneburg, S. et al. Targeted complement inhibition at synapses prevents microglial synaptic engulfment and synapse loss in demyelinating disease. Immunity 52, 167\u2013182.e167 (2020).","journal-title":"Immunity"},{"key":"72997_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.clim.2005.10.014","volume":"118","author":"DD Kim","year":"2006","unstructured":"Kim, D. D. & Song, W. C. Membrane complement regulatory proteins. Clin. Immunol. 118, 127\u2013136 (2006).","journal-title":"Clin. Immunol."},{"key":"72997_CR6","doi-asserted-by":"crossref","unstructured":"Iwasa, K. et al. CD59 Expression in skeletal muscles and its role in myasthenia gravis. Neurol. Neuroimmunol. Neuroinflamm. 10, e200057 (2023).","DOI":"10.1212\/NXI.0000000000200057"},{"key":"72997_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bbi.2017.04.023","volume":"65","author":"Z Wang","year":"2017","unstructured":"Wang, Z. et al. Low expression of complement inhibitory protein CD59 contributes to humoral autoimmunity against astrocytes. Brain Behav. Immun. 65, 173\u2013182 (2017).","journal-title":"Brain Behav. Immun."},{"key":"72997_CR8","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1177\/1352458515571446","volume":"21","author":"S Saadoun","year":"2015","unstructured":"Saadoun, S. & Papadopoulos, M. C. Role of membrane complement regulators in neuromyelitis optica. Mult. Scler. 21, 1644\u20131654 (2015).","journal-title":"Mult. Scler."},{"key":"72997_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jaut.2014.02.011","volume":"53","author":"H Zhang","year":"2014","unstructured":"Zhang, H. & Verkman, A. S. Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59. J. Autoimmun. 53, 67\u201377 (2014).","journal-title":"J. Autoimmun."},{"key":"72997_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott, N. J., Ronnback, L. & Hansson, E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41\u201353 (2006).","journal-title":"Nat. Rev. Neurosci."},{"key":"72997_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41582-021-00568-8","volume":"17","author":"SJ Pittock","year":"2021","unstructured":"Pittock, S. J., Zekeridou, A. & Weinshenker, B. G. Hope for patients with neuromyelitis optica spectrum disorders - from mechanisms to trials. Nat. Rev. Neurol. 17, 759\u2013773 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"72997_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon, V. A. et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202, 473\u2013477 (2005).","journal-title":"J. Exp. Med"},{"key":"72997_CR13","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon, V. A. et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364, 2106\u20132112 (2004).","journal-title":"Lancet"},{"key":"72997_CR14","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ana.21802","volume":"66","author":"JL Bennett","year":"2009","unstructured":"Bennett, J. L. et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann. Neurol. 66, 617\u2013629 (2009).","journal-title":"Ann. Neurol."},{"key":"72997_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awp309","volume":"133","author":"S Saadoun","year":"2010","unstructured":"Saadoun, S. et al. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133, 349\u2013361 (2010).","journal-title":"Brain"},{"key":"72997_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neulet.2013.12.030","volume":"565","author":"MA Anderson","year":"2014","unstructured":"Anderson, M. A., Ao, Y. & Sofroniew, M. V. Heterogeneity of reactive astrocytes. Neurosci. Lett. 565, 23\u201329 (2014).","journal-title":"Neurosci. Lett."},{"key":"72997_CR17","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/brain\/awl371","volume":"130","author":"SF Roemer","year":"2007","unstructured":"Roemer, S. F. et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130, 1194\u20131205 (2007).","journal-title":"Brain"},{"key":"72997_CR18","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41593-020-0602-1","volume":"23","author":"OA Bayraktar","year":"2020","unstructured":"Bayraktar, O. A. et al. Astrocyte layers in the mammalian cerebral cortex revealed by a single-cell in situ transcriptomic map. Nat. Neurosci. 23, 500\u2013509 (2020).","journal-title":"Nat. Neurosci."},{"key":"72997_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0092-8674(81)90037-4","volume":"26","author":"JD Termine","year":"1981","unstructured":"Termine, J. D. et al. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 26, 99\u2013105 (1981).","journal-title":"Cell"},{"key":"72997_CR20","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929\u201311947 (2014).","journal-title":"J. Neurosci."},{"key":"72997_CR21","doi-asserted-by":"publisher","first-page":"E440","DOI":"10.1073\/pnas.1104977108","volume":"108","author":"H Kucukdereli","year":"2011","unstructured":"Kucukdereli, H. et al. Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. PNAS 108, E440\u2013E449 (2011).","journal-title":"PNAS"},{"key":"72997_CR22","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0945-053X(00)00133-5","volume":"19","author":"RA Brekken","year":"2001","unstructured":"Brekken, R. A. & Sage, E. H. SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol. 19, 816\u2013827 (2001).","journal-title":"Matrix Biol."},{"key":"72997_CR23","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/mt.2012.12","volume":"20","author":"Y Yan","year":"2012","unstructured":"Yan, Y. et al. CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes. Mol. Ther. 20, 1338\u20131348 (2012).","journal-title":"Mol. Ther."},{"key":"72997_CR24","first-page":"99","volume":"59","author":"TA Fong","year":"1999","unstructured":"Fong, T. A. et al. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1\/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res. 59, 99\u2013106 (1999).","journal-title":"Cancer Res."},{"key":"72997_CR25","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara, N., Gerber, H. P. & LeCouter, J. The biology of VEGF and its receptors. Nat. Med. 9, 669\u2013676 (2003).","journal-title":"Nat. Med."},{"key":"72997_CR26","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jmgm.2007.05.001","volume":"26","author":"V Chandrasekaran","year":"2007","unstructured":"Chandrasekaran, V. et al. Molecular docking and analysis of interactions between vascular endothelial growth factor (VEGF) and SPARC protein. J. Mol. Graph Model. 26, 775\u2013782 (2007).","journal-title":"J. Mol. Graph Model."},{"key":"72997_CR27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1172\/JCI26316","volume":"116","author":"M Nozaki","year":"2006","unstructured":"Nozaki, M. et al. Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A. J. Clin. Investig. 116, 422\u2013429 (2006).","journal-title":"J. Clin. Investig."},{"key":"72997_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrneph.2016.70","volume":"12","author":"D Ricklin","year":"2016","unstructured":"Ricklin, D., Reis, E. S. & Lambris, J. D. Complement in disease: a defence system turning offensive. Nat. Rev. Nephrol. 12, 383\u2013401 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"72997_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/imr.12467","volume":"274","author":"G Hajishengallis","year":"2016","unstructured":"Hajishengallis, G. & Lambris, J. D. More than complementing Tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation. Immunol. Rev. 274, 233\u2013244 (2016).","journal-title":"Immunol. Rev."},{"key":"72997_CR30","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.1523\/JNEUROSCI.20-20-07505.2000","volume":"20","author":"LB Yang","year":"2000","unstructured":"Yang, L. B. et al. Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer\u2019s disease. J. Neurosci. 20, 7505\u20137509 (2000).","journal-title":"J. Neurosci."},{"key":"72997_CR31","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ana.25172","volume":"83","author":"EJ Goetzl","year":"2018","unstructured":"Goetzl, E. J. et al. High complement levels in astrocyte-derived exosomes of Alzheimer disease. Ann. Neurol. 83, 544\u2013552 (2018).","journal-title":"Ann. Neurol."},{"key":"72997_CR32","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1093\/brain\/awab102","volume":"144","author":"Y Takai","year":"2021","unstructured":"Takai, Y. et al. Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders. Brain 144, 2401\u20132415 (2021).","journal-title":"Brain"},{"key":"72997_CR33","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/brain\/awab394","volume":"145","author":"Y Guo","year":"2022","unstructured":"Guo, Y. et al. Spectrum of sublytic astrocytopathy in neuromyelitis optica. Brain 145, 1379\u20131390 (2022).","journal-title":"Brain"},{"key":"72997_CR34","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1001\/jamaneurol.2023.2974","volume":"80","author":"Y Fu","year":"2023","unstructured":"Fu, Y. et al. Rapid immunodot AQP4 assay for neuromyelitis optica spectrum disorder. JAMA Neurol. 80, 1105\u20131112 (2023).","journal-title":"JAMA Neurol."},{"key":"72997_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","volume":"261","author":"C Trebst","year":"2014","unstructured":"Trebst, C. et al. Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J. Neurol. 261, 1\u201316 (2014).","journal-title":"J. Neurol."},{"key":"72997_CR36","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/S0140-6736(19)31817-3","volume":"394","author":"BAC Cree","year":"2019","unstructured":"Cree, B. A. C. et al. Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2\/3 trial. Lancet 394, 1352\u20131363 (2019).","journal-title":"Lancet"},{"key":"72997_CR37","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1056\/NEJMoa1900866","volume":"381","author":"SJ Pittock","year":"2019","unstructured":"Pittock, S. J. et al. Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.  N. Engl. J. Med. 381, 614\u2013625 (2019).","journal-title":"N. Engl. J. Med."},{"key":"72997_CR38","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S1474-4422(20)30078-8","volume":"19","author":"A Traboulsee","year":"2020","unstructured":"Traboulsee, A. et al. Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial. Lancet Neurol. 19, 402\u2013412 (2020).","journal-title":"Lancet Neurol."},{"key":"72997_CR39","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(20)30070-3","volume":"19","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial. Lancet Neurol. 19, 391\u2013401 (2020).","journal-title":"Lancet Neurol."},{"key":"72997_CR40","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/ana.21837","volume":"66","author":"M Bradl","year":"2009","unstructured":"Bradl, M. et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann. Neurol. 66, 630\u2013643 (2009).","journal-title":"Ann. Neurol."},{"key":"72997_CR41","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti, C. F. et al. A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain 125, 1450\u20131461 (2002).","journal-title":"Brain"},{"key":"72997_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jns.2011.02.018","volume":"306","author":"K Fujihara","year":"2011","unstructured":"Fujihara, K. Neuromyelitis optica and astrocytic damage in its pathogenesis. J. Neurol. Sci. 306, 183\u2013187 (2011).","journal-title":"J. Neurol. Sci."},{"key":"72997_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","volume":"6","author":"S Jarius","year":"2020","unstructured":"Jarius, S. et al. Neuromyelitis optica. Nat. Rev. Dis. Prim. 6, 85 (2020).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"72997_CR44","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1146\/annurev-neuro-070918-050443","volume":"42","author":"BS Khakh","year":"2019","unstructured":"Khakh, B. S. & Deneen, B. The emerging nature of astrocyte diversity. Annu Rev. Neurosci. 42, 187\u2013207 (2019).","journal-title":"Annu Rev. Neurosci."},{"key":"72997_CR45","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-020-1999-0","volume":"578","author":"MA Wheeler","year":"2020","unstructured":"Wheeler, M. A. et al. MAFG-driven astrocytes promote CNS inflammation. Nature 578, 593\u2013599 (2020).","journal-title":"Nature"},{"key":"72997_CR46","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","volume":"32","author":"JL Zamanian","year":"2012","unstructured":"Zamanian, J. L. et al. Genomic analysis of reactive astrogliosis. J. Neurosci. 32, 6391\u20136410 (2012).","journal-title":"J. Neurosci."},{"key":"72997_CR47","doi-asserted-by":"publisher","first-page":"a020594","DOI":"10.1101\/cshperspect.a020594","volume":"7","author":"RJ Franklin","year":"2015","unstructured":"Franklin, R. J. & Goldman, S. A. Glia Disease and Repair-Remyelination. Cold Spring Harb. Perspect. Biol. 7, a020594 (2015).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"72997_CR48","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.3681","volume":"20","author":"L Mayo","year":"2014","unstructured":"Mayo, L. et al. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat. Med. 20, 1147\u20131156 (2014).","journal-title":"Nat. Med"},{"key":"72997_CR49","first-page":"4025","volume":"130","author":"T Chen","year":"2020","unstructured":"Chen, T. et al. Astrocyte-microglia interaction drives evolving neuromyelitis optica lesion. J. Clin. Invest 130, 4025\u20134038 (2020).","journal-title":"J. Clin. Invest"},{"key":"72997_CR50","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487 (2017).","journal-title":"Nature"},{"key":"72997_CR51","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41586-018-0119-x","volume":"557","author":"V Rothhammer","year":"2018","unstructured":"Rothhammer, V. et al. Microglial control of astrocytes in response to microbial metabolites. Nature 557, 724\u2013728 (2018).","journal-title":"Nature"},{"key":"72997_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2174\/156720506775697133","volume":"3","author":"MJ During","year":"2006","unstructured":"During, M. J. & Cao, L. VEGF, a mediator of the effect of experience on hippocampal neurogenesis. Curr. Alzheimer Res. 3, 29\u201333 (2006).","journal-title":"Curr. Alzheimer Res"},{"key":"72997_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15557","volume":"8","author":"C Morland","year":"2017","unstructured":"Morland, C. et al. Exercise induces cerebral VEGF and angiogenesis via the lactate receptor HCAR1. Nat. Commun. 8, 15557 (2017).","journal-title":"Nat. Commun."},{"key":"72997_CR54","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.0808698106","volume":"106","author":"AT Argaw","year":"2009","unstructured":"Argaw, A. T. et al. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. PNAS 106, 1977\u20131982 (2009).","journal-title":"PNAS"},{"key":"72997_CR55","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1038\/s41593-024-01746-9","volume":"27","author":"S Shahriar","year":"2024","unstructured":"Shahriar, S. et al. VEGF-A-mediated venous endothelial cell proliferation results in neoangiogenesis during neuroinflammation. Nat. Neurosci. 27, 1904\u20131917 (2024).","journal-title":"Nat. Neurosci."},{"key":"72997_CR56","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41580-023-00631-w","volume":"24","author":"L P\u00e9rez-Guti\u00e9rrez","year":"2023","unstructured":"P\u00e9rez-Guti\u00e9rrez, L. & Ferrara, N. Biology and therapeutic targeting of vascular endothelial growth factor A. Nat. Rev. Mol. Cell Bio 24, 816\u2013834 (2023).","journal-title":"Nat. Rev. Mol. Cell Bio"},{"key":"72997_CR57","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41582-024-01014-1","volume":"20","author":"A Uzawa","year":"2024","unstructured":"Uzawa, A. et al. NMOSD and MOGAD: an evolving disease spectrum. Nat. Rev. Neurol. 20, 602\u2013619 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"72997_CR58","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neures.2023.02.001","volume":"197","author":"M Albini","year":"2023","unstructured":"Albini, M., Krawczun-Rygmaczewska, A. & Cesca, F. Astrocytes and brain-derived neurotrophic factor (BDNF). Neurosci. Res. 197, 42\u201351 (2023).","journal-title":"Neurosci. Res"},{"key":"72997_CR59","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41586-024-07079-8","volume":"627","author":"AM Afzali","year":"2024","unstructured":"Afzali, A. M. et al. B cells orchestrate tolerance to the neuromyelitis optica autoantigen AQP4. Nature 627, 407\u2013415 (2024).","journal-title":"Nature"},{"key":"72997_CR60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2306572120","volume":"120","author":"SA Sagan","year":"2023","unstructured":"Sagan, S. A. et al. T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity. PNAS 120, e2306572120 (2023).","journal-title":"PNAS"},{"key":"72997_CR61","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1677\/JME-10-0122","volume":"46","author":"MA Arevalo","year":"2011","unstructured":"Arevalo, M. A. et al. Selective estrogen receptor modulators as brain therapeutic agents. J. Mol. Endocrinol. 46, R1\u2013R9 (2011).","journal-title":"J. Mol. Endocrinol."},{"key":"72997_CR62","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.4049\/jimmunol.1600135","volume":"197","author":"KB Shi","year":"2016","unstructured":"Shi, K. B. et al. CFHR1-modified neural stem cells ameliorated brain injury in a mouse model of neuromyelitis optica spectrum disorders. J. Immunol. 197, 3471\u20133480 (2016).","journal-title":"J. Immunol."},{"key":"72997_CR63","doi-asserted-by":"crossref","unstructured":"Pan, Y. et al. Rational design of P450 aMOx for improving anti-Markovnikov selectivity based on the \u201cbutterfly\u201d model. Front. Mol. Biosci. 9, 888721 (2022).","DOI":"10.3389\/fmolb.2022.888721"},{"key":"72997_CR64","doi-asserted-by":"crossref","unstructured":"Fan, H. L. et al. A Nanoplasmonic portable molecular interaction platform for high-throughput drug screening. Adv. Funct. Mater. 32, 2203635 (2022).","DOI":"10.1002\/adfm.202203635"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72997-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72997-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72997-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:01:54Z","timestamp":1784232114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72997-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72997"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72997-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"24 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6348"}}